2023 SDPA Fall Conference Recap: Day 2

Larry Gibson/Adobe Stock

Robyn Siperstein, MD, FAAD: Initiating a Patient-First Dialogue in Cosmetic Dermatology

Robyn Siperstein, MD, FAAD, reviews highlights and takeaways from her SDPA Fall 2023 sessions discussing considerations in cosmetic dermatology, thought-changing research in aesthetics, and more.

Secukinumab Demonstrates Efficacy in Reducing Tunnels Associated With Hidradenitis Suppurativa

More than 80% of patients did not experience an increase in number of draining tunnels associated with HS by week 52.

Enhancing the Patient Experience Through Addressing Pain Points and “Being Extra”

Joe Cari, MPAS, PA-C, spoke to SDPA Fall Conference attendees about the importance of maximizing the patient journey from arrival to check out and beyond.

Modified Irritation Study Reveals Tazarotene 0.045% Less Irritating Than Trifarotene, Adapalene

Tazarotene was significantly less irritating to the skin than trifarotene and numerically less irritating than adapalene, according to a poster presented at SDPA Fall 2023.

4 Tips and Considerations for Selecting a Systemic Treatment for Your Patients With Psoriasis

Douglas DiRuggiero, DMSc, PA-C, presented a comprehensive session at the SDPA fall conference on treatment selection for patients with psoriasis.

Investigation of Risk Factors for Metastatic Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients

A poster presented at SDPA’s fall conference revealed key insights into the importance of close monitoring and preventative measures in patients with cSCC.

Make sure to keep up to date with the latest in coverage from the conference and subscribe to Dermatology Times to receive daily email updates.